Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | HCID 18422065 | HCID 18422065 | — |
| Solvent | Water | HCID 962 | — |
| Product | HCID 9914896 | HCID 9914896 | — |
Reaction Steps
Using an analogous procedure to that described in Example 3, a mixture of N-{3-[3-(4-methylpiperazin-1-ylmethyl)benzamido]-4-methylphenyl}-2-chloropyridine-4-carboxamide (0.5 g) and morpholine (5 ml) was stirred and heated to 110° C. for 16 hours. The resultant solution was cooled to ambient temperature and poured into water and extracted with methylene chloride. The organic phase was evaporated and the residue was purified by column chromatography on an isolute SCX ion exchange column using a 99:1 mixture of methanol and a saturated aqueous ammonium hydroxide solution as eluent. There was thus obtained the title compound (0.023 g); Mass Spectrum: M+H+529.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06455520B1 |
|---|
| Source dataset | uspto-grants-2002_09 |
|---|
| ORD ID | ord-a34fa851986b440f9722dd26674e7fbc |
|---|
| Source note | uspto-grants-2002_09 |
|---|